Dr. Scott Rocklage is currently a Managing Partner at 5 AM Venture Management LLC. He joined the company in 2003 as a Venture Partner and became Managing Partner a year later. As a venture capitalist firm, the organization provides financial support to start-up companies in the healthcare industry.
Being highly experienced in the pharmaceutical industry, Scott Rocklage is well-placed to advise such companies on the best course of action. He has successfully led the company in the acquisition of big clients such as Alexza Pharmaceuticals, DVS Sciences and Aprea Pharmaceuticals. Most of the companies supported by 5AM Venture Management have grown to become highly successful. Dr.Rocklage is knowledgeable in the scientific aspect of the industry and is also a professional businessman. These two traits make him ideal for his job. He also has notable leadership skills, and this is part of what got him to rise to his position in the company within a year.
He has been in the healthcare industry for over 30 years, and during this period, Dr. Scott Rocklage has succeeded in convincing the FDA to approve several drug applications. He has also invented or participated in the creation of more than 30 US patents.
Dr. Rocklage also serves as the Board Chairman of Achaogen, Semprus, and Relypsa. Besides, he forms part of the boards of Pulmatrix, WaveRX, Whitehead Institute, Variation and resume him.
He has a great background in the field of Chemistry. Dr. Rocklage received his Bachelor in Science degree from the University of California in Berkeley. His Ph.D. in Chemistry was attained from the Massachusetts Institute of Technology (MIT), and he currently has over 100 peer-reviewed publications.
Besides being a successful chemist, Mr. Rocklage is a businessman with investments in several companies.
Dr.Rocklage has a long history in the healthcare industry. Between 1994 and 2003, he served as the chairman and CEO of Cubist Pharmaceuticals, a publicly traded company that has been defunct as from 2015. Also, he served as the CEO and president of Nycomed Salutar, an imaging firm, from 1986 to 1989.
He has been the Executive Chairman of three companies- Ilypsa, Miikana, and Semprus. Dr. Rocklage has played key roles in research and development at Nycomed and Catalytica, Inc. He has also served on the boards of companies such as Relypsa, Novira, and Kinestral and more information click here.